NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can diabetes drug beat statins for fatty liver? new trial aims to find out
Disease control Not yet recruitingThis study tests whether empagliflozin (a diabetes drug) works better than statins for treating non-alcoholic fatty liver disease (NAFLD) and its more severe form, NASH. About 400 adults who are obese, diabetic, and have high cholesterol will take one of four treatments daily for…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: PHASE4 • Sponsor: Badr University • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New drug miricorilant tested for fatty liver disease safety
Knowledge-focused Not yet recruitingThis early-stage study tests the safety and how the body processes the drug miricorilant in 15 adults with MASH, a serious fatty liver condition. Participants will take the drug and be monitored for side effects and drug levels in the blood. The goal is to gather information for …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Phase: PHASE1 • Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 10:20 UTC